Pharma braces for tougher Treasury scrutiny of China deals as outbound investment rules expected Thursday

Pharma is bracing for tougher Treasury scrutiny of China deals, with draft outbound investment rules expected Thursday.

Detected & updated continuously · Source: Nebula